Clinical Trials Directory

Trials / Unknown

UnknownNCT05927831

Grape Seed Extract VS Low Level Laser Therapy for Dentin Hypersensitivity

Comparison of the Effectiveness of Grape Seed Extract (GSE) and Low-level Laser Therapy in the Management of Dentin Hypersensitivity: A Randomized Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Manipal University College Malaysia · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Dentin hypersensitivity (DH) is a common clinical problem frequently seen in dental patients. According to Splieth et al., the prevalence of dentin hypersensitivity is 3-98% in adult population.DH is described as a short, sharp pain or discomfort that responses to certain stimuli, typically thermal, tactile, osmotic or chemical, due to exposed dentinal surface which can be explained by the hydrodynamic theory. The laser is a narrow, focused beam of light emitted to vaporise, fuse, melt, or seal dentinal tubules using laser heat to induce hydroxyapatite crystals for recrystallisation of the mineral component of dentine. The obliteration of dentinal tubules is caused by heat generated by laser beam which inhibits the transmission of the stimulus in the dentinal tubules. Grape seed extract contains proanthocyanidins (PA) which is able to bind to proline-rich proteins, like collagen, and contributes in enzyme proline hydroxylase activity that is essential for the biosynthesis of collagen in the dentin. The cross-linking action of collagen fibrils in dentin also able to prevent mineral loss.

Conditions

Interventions

TypeNameDescription
DRUGGrape Seed ExtractGrape seed extract will be applied in the form of a gel on the tooth surface
DEVICELow-level laser therapyThe device will be set at a wavelength of 810 nm, with a power output of 0.5 watts tip of diameter 300 μ in non-contact mode

Timeline

Start date
2023-05-15
Primary completion
2024-01-15
Completion
2024-01-15
First posted
2023-07-03
Last updated
2023-07-03

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT05927831. Inclusion in this directory is not an endorsement.